18F-PEG3-FPN

N/A

Report date: 2026/05/02 20:00:18
NME

Base Information

Drug Name18F-PEG3-FPN
Drug Alias Name18F-FDG
ClassificationRadiation-emitting products > Radioactive diagnostic agentSmall molecules > Heterocyclic drugs
Mechanisms of ActionMelanin modulators
TargetsMelanin
Therapy Area/IndicationsMetastatic breast cancerCardiovascular DiseasesLung Neoplasms +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesWuhan Union Hospital
China Registration ClassN/A

Develop Information

Active CompaniesSociety Of Nuclear Medicine And Molecular ImagingWuhan Union HospitalThe University Of California Davis +[6] 
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancerCardiovascular DiseasesLung Neoplasms +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A